Loading cancer entity…
Loading cancer entity…
Clinical trials
6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07306962 | Virtual Lesion Segmentation and Mandibular Ameloblastoma Radiographic Safety Margin | recruiting | N/A | 10 | Alexandria UniversityOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT06819605 | Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma(NETCAM-RCT) | not yet recruiting | Phase 2 / Phase 3 | 46 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 0 | Feb 11, 2025 | clinicaltrials |
| NCT06759610 | Effect of Tetracycline Socked Pack on Acceleration of Healing During Marsupialization | completed | N/A | 14 | Minia UniversityOTHER | 1 | Jan 6, 2025 | clinicaltrials |
| NCT06653517 |
Data updated 22 days agoSource updated Dec 29, 2025source: clinicaltrials
| Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma(NETCAM) |
| recruiting |
| Phase 2 |
| 12 |
| Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER |
| 1 |
| Oct 22, 2024 |
| clinicaltrials |
| NCT06264778 | Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma | unknown | Phase 3 | 10 | Shandong UniversityOTHER | 0 | Feb 20, 2024 | clinicaltrials |
| NCT02367859 | Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma | completed | Phase 2 | 1 | Stanford UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |